BG105011A - Лекарствена форма, съдържаща пароксетин - Google Patents

Лекарствена форма, съдържаща пароксетин

Info

Publication number
BG105011A
BG105011A BG105011A BG10501100A BG105011A BG 105011 A BG105011 A BG 105011A BG 105011 A BG105011 A BG 105011A BG 10501100 A BG10501100 A BG 10501100A BG 105011 A BG105011 A BG 105011A
Authority
BG
Bulgaria
Prior art keywords
composition containing
containing paroxetine
hemihydrate
paroxetine
formulated
Prior art date
Application number
BG105011A
Other languages
English (en)
Inventor
David Elder
Graham LEONARD
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BG105011A publication Critical patent/BG105011A/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретението се отнася до пароксетин хидрохлоридвъв форма, различна от полухидратната, която се формулира в капсули при такива условия, че няма забележимо превръщане до полухидрат по време на получаването си.
BG105011A 1998-05-13 2000-11-30 Лекарствена форма, съдържаща пароксетин BG105011A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810180.1A GB9810180D0 (en) 1998-05-13 1998-05-13 Novel formulation
PCT/GB1999/001522 WO1999058116A2 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine

Publications (1)

Publication Number Publication Date
BG105011A true BG105011A (bg) 2001-07-31

Family

ID=10831926

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105011A BG105011A (bg) 1998-05-13 2000-11-30 Лекарствена форма, съдържаща пароксетин

Country Status (20)

Country Link
EP (1) EP1077685A2 (bg)
JP (1) JP2002514593A (bg)
KR (1) KR20010043545A (bg)
CN (1) CN1309557A (bg)
AP (1) AP2000001985A0 (bg)
AU (1) AU3941099A (bg)
BG (1) BG105011A (bg)
BR (1) BR9910402A (bg)
CA (1) CA2331849A1 (bg)
EA (1) EA200001173A1 (bg)
GB (1) GB9810180D0 (bg)
HU (1) HUP0101931A3 (bg)
ID (1) ID27018A (bg)
IL (1) IL139596A0 (bg)
NO (1) NO20005681L (bg)
PL (1) PL344872A1 (bg)
SK (1) SK16972000A3 (bg)
TR (1) TR200003351T2 (bg)
WO (1) WO1999058116A2 (bg)
ZA (1) ZA200006465B (bg)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1161241B1 (de) * 1999-03-12 2005-12-07 Aesica Pharmaceuticals Ltd. Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
HU226912B1 (en) * 2000-04-07 2010-03-01 Richter Gedeon Nyrt New paroxetin salt and medicament containing it
WO2013145750A1 (ja) * 2012-03-29 2013-10-03 杏林製薬株式会社 カプセル製剤
DE102013207447A1 (de) 2013-04-24 2014-10-30 Evonik Degussa Gmbh Verfahren und Vorrichtung zur Herstellung von Octachlortrisilan
CN103520131B (zh) * 2013-10-12 2019-05-14 浙江华海药业股份有限公司 盐酸帕罗西汀半水合物胶囊的制备方法
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2216934A1 (en) * 1995-04-03 1996-10-10 Abbott Laboratories Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
GB9724544D0 (en) * 1997-11-21 1998-01-21 Smithkline Beecham Plc Novel Formulation

Also Published As

Publication number Publication date
PL344872A1 (en) 2001-11-19
EP1077685A2 (en) 2001-02-28
KR20010043545A (ko) 2001-05-25
GB9810180D0 (en) 1998-07-08
BR9910402A (pt) 2001-01-09
NO20005681L (no) 2000-12-01
WO1999058116A2 (en) 1999-11-18
CN1309557A (zh) 2001-08-22
AU3941099A (en) 1999-11-29
HUP0101931A3 (en) 2002-10-28
AP2000001985A0 (en) 2000-12-31
HUP0101931A2 (hu) 2002-04-29
IL139596A0 (en) 2002-02-10
WO1999058116A3 (en) 2000-02-17
TR200003351T2 (tr) 2001-03-21
NO20005681D0 (no) 2000-11-10
EA200001173A1 (ru) 2001-04-23
SK16972000A3 (sk) 2001-06-11
ID27018A (id) 2001-02-22
JP2002514593A (ja) 2002-05-21
ZA200006465B (en) 2001-11-09
CA2331849A1 (en) 1999-11-18

Similar Documents

Publication Publication Date Title
EP0655459A3 (en) Process for the preparation of the 1,2-double bond of 4-aza steroids and crystalline Proscor (R) and pharmaceutical preparations thereof.
PL319384A1 (en) Steroic compositions from soap mass
BG102259A (bg) Състави с контролирано освобождаване на пароксетин
PL345215A1 (en) Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
HK1042698B (zh) 新的二苯脲化合物、其製備方法和含有該化合物的藥物組合物
MX9700273A (es) Benzamidinas sustituidas, su preparacion y empleo como sustancias medicamentosas.
BG105197A (bg) Полиморфна форма на лекарствено средство
YU12000A (sh) Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova
BG105011A (bg) Лекарствена форма, съдържаща пароксетин
GB0029774D0 (en) Clay composition
ZA99477B (en) Process for the preparation of (-)CIS-3-Hydroxy-1-Methyl-4-(2,4,6-Trimethoxyphenyl)Piperidine.
WO1999037291A3 (de) Verwendung von substituierten sulfonamiden als antivirale mittel und neue stoffe
PL352104A1 (en) Oral composition containing perlite
HUP0202379A3 (en) New compounds, process for producing them and pharmaceutical compositions containing them
SI1206452T1 (en) Novel method for preparing benzoperhydroisoindole compounds
HUP0000308A2 (en) New cyano-indole serotonin-reuptake inhibitor compounds, a process for their preparation and pharmaceutical compositions containing them
BG105010A (bg) Нова лекарствена форма съдържаща пароксетин
EP1044394A4 (en) METHOD FOR PRODUCING A RADIO-SENSITIVE COMPOSITION
HK1029025A1 (en) Compressed chloramine-t tablets and method for the production thereof
HK1051845A1 (en) Substituted 1 and 2 naphthol mannich bases
IL148161A0 (en) Process for the preparation of 2-cyanopyridines
HUP0200187A3 (en) A process for the preparation of 1,4,7,10-tetraazacyclododecane
CA2331758A1 (en) Method for the stereochemically controlled production of isomerically pure highly substituted azacyclic compounds
YU71400A (sh) Poboljšani postupak za pripremanje farmaceutski dragocenih derivata norbenzomorfana
WO1999040078A3 (en) Process for the preparation of sotolon